Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study

被引:6
|
作者
Zhang, Xiu-Ping [1 ]
Xu, Shuai [2 ]
Gao, Yuan-Xing [1 ]
Zhao, Zhi-Ming [1 ]
Zhao, Guo-Dong [1 ]
Hu, Ming-Gen [1 ]
Tan, Xiang-Long [1 ]
Lau, Wan Yee [1 ,3 ]
Liu, Rong [1 ,2 ,4 ]
机构
[1] Chinese Peoples Liberat Army PLA, Chinese PLA Gen Hosp, Fac Hepatobiliary Pancreat Surg, Med Sch,Med Ctr 1, Beijing, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Liver Transplantat & Hepatobiliary Surg, Jinan, Peoples R China
[3] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China
[4] Chinese Peoples Liberat Army PLA Gen Hosp, Fac Hepatobiliary Pancreat Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China
关键词
early recurrence; late recurrence; pancreatic ductal adenocarcinoma; pancreaticoduodenectomy; postrecurrence survival; ISOLATED LOCAL RECURRENCE; BODY RADIATION-THERAPY; SURGICAL RESECTION; CANCER; SURVIVAL; CHEMOTHERAPY; TRIAL;
D O I
10.1097/JS9.0000000000000296
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background:Survival after pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) remains poor because of high incidences of recurrence. The risk factors, patterns, and long-term prognosis in patients with early recurrence and late recurrence (ER and LR) for PDAC after PD were studied. Methods:Data from patients who underwent PD for PDAC were analyzed. Recurrence was divided into ER (ER <= 1 years) and LR (LR >1 years) using the time to recurrence after surgery. Characteristics and patterns of initial recurrence, and postrecurrence survival (PRS) were compared between patients with ER and LR. Results:Among the 634 patients, 281 (44.3%) and 249 (39.3%) patients developed ER and LR, respectively. In the multivariate analysis, preoperative CA19-9 levels, resection margin status, and tumor differentiation were significantly associated with both ER and LR, while lymph node metastasis and perineal invasion were associated with LR. Patients with ER, when compared with patients with LR, showed a significantly higher proportion of liver-only recurrence (P<0.05), and worse median PRS (5.2 vs. 9.3 months, P<0.001). Lung-only recurrence had a significantly longer PRS when compared with liver-only recurrence (P<0.001). Multivariate analysis demonstrated that ER and irregular postoperative recurrence surveillance were independently associated with a worse prognosis (P<0.001). Conclusion:The risk factors for ER and LR after PD are different for PDAC patients. Patients who developed ER had worse PRS than those who developed LR. Patients with lung-only recurrence had a significantly better prognosis than those with other recurrent sites.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 50 条
  • [1] Recurrence of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: Is there a role for locoregional treatment?
    Gangi, Alexandra
    Menon, Vijay G.
    Sheckley, Marwan
    Tuli, Richard
    Hendifar, Andrew Eugene
    Wachsman, Ashley
    Nissen, Nicholas N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Lymph Node Status and Patterns of Recurrence Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma
    Weiser, R.
    Lahat, G.
    Lubezky, N.
    Gerstenhaber, F.
    Nizri, E.
    Nachmany, I.
    Goichman, J.
    Nakache, R.
    Klausner, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S168 - S168
  • [3] Tumor Recurrence Is Independent of Pancreatic Fistula in Patients after Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma
    Assifi, M. Mura
    Zhang, Sarah
    Leiby, Benjamin E.
    Pequignot, Edward C.
    Xia, Brent
    Rosato, Ernest
    Lavu, Harish
    Kennedy, Eugene P.
    Yeo, Charles J.
    Berger, Adam C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (04) : 621 - 627
  • [4] A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study
    Zhang, Xiu-Ping
    Gao, Yuan-Xing
    Xu, Shuai
    Zhao, Guo-Dong
    Hu, Ming-Gen
    Tan, Xing-Long
    Zhao, Zhi-Ming
    Liu, Rong
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2022, 106
  • [5] Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China
    Liu, Weikang
    Tang, Bingjun
    Wang, Feng
    Qu, Chang
    Hu, Hao
    Zhuang, Yan
    Gao, Hongqiao
    Xie, Xuehai
    Tian, Xiaodong
    Yang, Yinmo
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 3055 - 3069
  • [6] Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
    Van den Broeck, A.
    Sergeant, G.
    Ectors, N.
    Van Steenbergen, W.
    Aerts, R.
    Topal, B.
    [J]. EJSO, 2009, 35 (06): : 600 - 604
  • [7] Comment on 'A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study'
    Gong, Junsheng
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 1070 - 1071
  • [8] Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma
    Nappo, Gennaro
    Donisi, Greta
    Capretti, Giovanni
    Ridolfi, Cristina
    Pagnanelli, Michele
    Nebbia, Martina
    Bozzarelli, Silvia
    Petitti, Tommasangelo
    Gavazzi, Francesca
    Zerbi, Alessandro
    [J]. CURRENT ONCOLOGY, 2023, 30 (04) : 3708 - 3720
  • [9] Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
    Sugawara, Toshitaka
    Ban, Daisuke
    Nishino, Jo
    Watanabe, Shuichi
    Maekawa, Aya
    Ishikawa, Yoshiya
    Akahoshi, Keiichi
    Ogawa, Kosuke
    Ono, Hiroaki
    Kudo, Atsushi
    Tanaka, Shinji
    Tanabe, Minoru
    [J]. PLOS ONE, 2021, 16 (04):
  • [10] Predictors of Early Recurrence After Resection of Pancreatic Ductal Adenocarcinoma
    Anazawa, T.
    Tsuchiya, T.
    Kenjo, A.
    Kimura, T.
    Haga, J.
    Sato, T.
    Sato, N.
    Gotoh, M.
    [J]. PANCREAS, 2012, 41 (07) : 1161 - 1162